Pembrolizumab
Merck
['mbc', 'pivotal']
 from presenting pivotal work on mutational signatures and patterns of genomic instability(apoebec and hrd) linked to endocrine resistance in er+ mbc 
Associate Attending at Memorial Sloan Kettering Cancer Center